Stemgent Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Stemgent Inc (Stemgent), a part of the ReproCELL Group is a biotechnology company that focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The companys product portfolio comprises antibodies, cell lines, cytokines / proteins, differentiation, matrices, media, reprogramming systems, small molecules and transfection. It also offers iPS cell services and training courses for research scholars of various research laboratories. These training courses cover all essential protocols for lentiviral and mRNA reprogramming and human induced pluripotent (iPS) cell culture techniques in a hands-on laboratory environment. The company operates research sites in Cambridge, Massachusetts and San Diego, California. Stemgent is headquartered in Cambridge, Massachusetts, the US.

Stemgent Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stemgent Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stemgent Inc, Medical Devices Deals, 2012 to YTD 2018 8
Stemgent Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Stemgent Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Stemgent Completes Acquisition Of Human Tissue Business From Asterand For US$9 Million 10
Venture Financing 12
Stemgent Raises US$11.3 Million In Venture Financing 12
Stemgent Raises US$6.3 Million In Series C Financing 13
Licensing Agreements 14
Stemgent Enters Into Licensing Agreement With iPS Academia For Induced Pluripotent Stem Cell Patent Portfolio 14
Asset Transactions 15
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 15
Stemgent Inc - Key Competitors 16
Stemgent Inc - Key Employees 17
Stemgent Inc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Stemgent Inc, Pharmaceuticals & Healthcare, Key Facts 2
Stemgent Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stemgent Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stemgent Inc, Medical Devices Deals, 2012 to YTD 2018 8
Stemgent Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Stemgent Completes Acquisition Of Human Tissue Business From Asterand For US$9 Million 10
Stemgent Raises US$11.3 Million In Venture Financing 12
Stemgent Raises US$6.3 Million In Series C Financing 13
Stemgent Enters Into Licensing Agreement With iPS Academia For Induced Pluripotent Stem Cell Patent Portfolio 14
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 15
Stemgent Inc, Key Competitors 16
Stemgent Inc, Key Employees 17
Stemgent Inc, Other Locations 18

List Of Figures

List of Figures
Stemgent Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stemgent Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Stemgent Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stemgent Inc, Medical Devices Deals, 2012 to YTD 2018 8

Stemgent Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Stemgent Inc (Stemgent), a part of the ReproCELL Group is a biotechnology company that focuses on the development of innovative technology and application solutions for the advancement of stem cell

USD 250 View Report

Stemgent Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Stemgent Inc Company Profile is a detailed strategic and analytical report on Stemgent Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Verisante Technology Inc - Medical Equipment - Deals and Alliances Profile

Verisante Technology Inc (Verisante) is a medical device company that develops and commercializes systems for the early detection of cancer. The companys key product offerings include Verisante Aura, Verisante Core

USD 250 View Report

US Oil Sands Inc - Oil & Gas - Deals and Alliances Profile

US Oil Sands Inc (US Oil Sands), formerly Earth Energy Resources Inc, is an oil and gas company that explores and develops oil sand properties. The company has developed a

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available